Revision of Kari Alitalo
syncWikidata syncChanges
| Field | Before | After |
|---|---|---|
image_id | 104466 | 208414 |
subtitle | Finnish research professor (Academy of Finland), director of Translational Cancer Biology research program (AlitaloLab, Institute of Biomedicine, University of Helsinki) and director of Wihuri Research Institute (Helsinki) | Finnish research professor |
description | <p class="article-desc">Kari Kustaa Alitalo (born 21 May 1952 in Kuopio) is a Finnish MD and a medical researcher. He is a foreign associated member of the National Academy of Sciences of the US. He became famous for his discoveries of several receptor tyrosine kinases (RTKs) and the first growth factor capable of inducing lymphangiogenesis: vascular endothelial growth factor C (VEGF-C).</p> | Kari Kustaa Alitalo is a Finnish MD and a medical researcher. He is a foreign associated member of the National Academy of Sciences of the US. He became famous for his discoveries of several receptor tyrosine kinases (RTKs) and the first growth factor capable of inducing lymphangiogenesis: vascular endothelial growth factor C (VEGF-C). In the years 1996–2007 he was Europe's second most cited author in the field of cell biology. Alitalo is currently serving as an Academy Professor for the Academy of Finland. |
entity_type | — | person |
Added handles: viaf: 166963968, viaf: 5532152563114515560009